Global Lung Cancer Therapeutics Market Set to Reach USD 48,725.9 Million by 2026 with an Impressive CAGR of 13.4% growth over the forecast period 2022 to 2032
The USA is the largest market for NSCLC owing to the high incidence rate rise in the aging population. In addition, with the advent of new treatment…Read More